Jesse Fishman

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Madrigal Pharmaceuticals (United States)(Current)

University of Michigan

Jesse Fishman is an author at Madrigal Pharmaceuticals (United States) specializing in liver disease, nonalcoholic steatohepatitis associated fibrosis, and cost-effectiveness modeling.

ORCID

Publications per year

2022–2024

Publications

Early Cost-Effectiveness and Price Threshold Analyses of Resmetirom: An Investigational Treatment for Management of Nonalcoholic Steatohepatitis

Mehdi Javanbakht, Jesse Fishman, Eoin Moloney et al. · PharmacoEconomics - Open · 2022 · 41 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cost burden of cirrhosis and liver disease progression in metabolic dysfunction–associated steatohepatitis: A US cohort study

Jesse Fishman, Christina Qian, Yestle Kim et al. · Journal of Managed Care & Specialty Pharmacy · 2024 · 17 citations · Full text

Medicine, Internal Medicine, Pathology +16

Healthcare resource utilization and costs of care in the United States for patients with non-alcoholic steatohepatitis

Elliot B. Tapper, Machaon Bonafede, Jesse Fishman et al. · Journal of Medical Economics · 2023 · 15 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

The incremental cost of non-alcoholic steatohepatitis and type 2 diabetes in the United States using real-world data

Jesse Fishman, Elliot B. Tapper, Stephen Dodge et al. · Current Medical Research and Opinion · 2023 · 12 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

1–4 of 4